MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2

Although the spread of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a worldwide pandemic, there are currently no virus-specific drugs that are fully effective against SARS-CoV-2. Only a limited number of human-derived cells are capable of supporting SARS-CoV-2 replica...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Kentaro, Sasaki, Michihito, Sanaki, Takao, Toba, Shinsuke, Takahashi, Yoshimasa, Orba, Yasuko, Hall, William W., Maenaka, Katsumi, Sawa, Hirofumi, Sato, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940632/
https://www.ncbi.nlm.nih.gov/pubmed/33686154
http://dx.doi.org/10.1038/s41598-021-84882-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940632/
https://www.ncbi.nlm.nih.gov/pubmed/33686154
http://dx.doi.org/10.1038/s41598-021-84882-7

Ejemplares similares